Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 11, 2002, Pages 1936-1941

  Burke, Allen P ^a   Fonseca, V ^a   Kolodgie, Frank ^a   Zieske, Arthur ^a   Fink, Louis ^a   Virmani, Renu ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Coronary artery disease; Diabetes; Homocysteine; Sudden death; Thrombosis

Indexed keywords

HOMOCYSTEINE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SMOKING; SUDDEN DEATH;

ADULT; ANALYSIS OF VARIANCE; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; FIBROSIS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0036848968     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000035405.16217.86     Document Type: Article

References (39)

1. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1-31.
2. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 1996;94:2410-2416.
3. Israelsson B, Brattstrom LE, Hultberg BL. Homocysteine and myocardial infarction. Atherosclerosis. 1988;71:227-233.
4. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995;346:1395-1398.
5. Tribouilloy CM, Peltier M, Iannetta Peltier MC, Trojette F, Andrejak M, Lesbre JP. Plasma homocysteine and severity of thoracic aortic atherosclerosis. Chest. 2000;118:1685-1689.
6. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
7. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103:934-940.
8. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369-6373.
9. Verhoef P, Hennekens CH, Allen RH, Stabler SP, Willett WC, Stampfer MJ. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol. 1997;79:799-801.
10. Burke AP, Farb A, Malcom GT, Liang Y-H, Smialek J, Virmani R. Coronary risk factors and plaque morphology in patients with coronary disease dying suddenly. N Engl J Med. 1997;336:1276-1282.
11. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
12. Farb A, Burke AP, Tang A, Liang Y-H, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core: A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354-1363.
13. Fonseca VA, Stone A, Munshi M, Baliga BS, Aljada A, Thusu K, Fink L, Dandona P. Oxidative stress in diabetic macrovascular disease: Does homocysteine play a role? South Med J. 1997;90:903-906.
14. Burke AP, Farb A, Pestaner J, Malcom GT, Zieske A, Kutys R, Smialek J, Virmani R. Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks. Circulation. 2002;105:419-424.
15. McGill H, McMahan C, Malcom G, Oalmann M, Strong J. Relation of glycohemoglobin and adiposity to atherosclerosis in youth: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol. 1995;15:431-440.
16. Strong JP, Malcom GT, Oalmann MC. Environmental and genetic risk factors in early human atherogenesis: Lessons from the PDAY study. Pathobiol Determinants Atheroscler Youth Pathol Int. 1995;45:403-408.
17. Tracy R, Mercante D, Moncada A, Berenson G. Quantitation of hypertensive nephrosclerosis on an objective rational scale of measure in adults and children. Am J Clin Pathol. 1986;85:312-318.
18. Virmani R, Avolio AP, Mergner WJ, Robinowitz M, Herderick EE, Cornhill JF, Guo SY, Liu TH, Ou DY, O'Rourke M. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis: Comparison between occidental and Chinese communities. Am J Pathol. 1991;139:1119-1129.
19. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL, Davis CE. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1998;98:204-210.
20. Senaratne MP, Griffiths J, Nagendran J. Elevation of plasma homocysteine levels associated with acute myocardial infarction. Clin Invest Med. 2000;23:220-226.
21. Al-Obaidi MK, Stubbs PJ, Amersey R, Noble MI. Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes. Heart. 2001;85:380-384.
22. Al-Obaidi MK, Stubbs PJ, Collinson P, Conroy R, Graham I, Noble MI. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol. 2000;36:1217-1222.
23. Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith GD. Homocysteine and coronary heart disease in the Caerphilly cohort: A 10 year follow up. Heart. 2001;85:153-158.
24. Lentz SR. Does homocysteine promote atherosclerosis? Arterioscler Thromb Vasc Biol. 2001;21:1385-1386.
25. Hofmann MA, Lall E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ, Kohl B, Rao V, Kiseil W, Stern DM, Schmidt AM. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001;107:675-683.
26. Zhou J, Moller J, Danielson CC, Bentzon J, Ravn HB, Austin RC, Falk E. Hyperhomocysteinemia promotes the development of collagen-rich and stable plaques in apE-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:1470-1476.
27. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
28. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000;102:2479-2483.
29. Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Hypethomocysteinemia increases risk of death, especially in type 2 diabetes: 5-Year follow-up of the Hoorn Study. Circulation. 2000;101:1506-1511.
30. Stehouwer CD, Gall MA, Hougaard P, Jakobs C, Parving HH. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int. 1999;55:308-314.
31. Poirier LA, Brown AT, Fink LM, Wise CK, Randolph CJ, Delongchamp RR, Fonseca VA. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism. 2001;50:1014-1018.
32. Dicker-Brown A, Fonseca VA, Fink LM, Kern PA. The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: Studies in hepatocytes. Atherosclerosis. 2001;158:297-301.
33. Kokame K, Kato H, Miyata T. Nonradioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells. Methods. 1998;16:434-443.
34. Wang G, Siow YL, OK. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: A possible role for protein kinase C. Biochem J. 2000;352 Pt 3:817-826.
35. Duarte NL, Wang XL, Wilcken DE. Effects of anticoagulant and time of plasma separation on measurement of homocysteine. Clin Chem. 2002;48:665-668.
36. Nauck M, Bisse E, Wieland H. Pre-analytical conditions affecting the determination of the plasma homocysteine concentration. Clin Chem Lab Med. 2001;39:675-680.
37. Caliskan S, Kuralay F, Onvural B. Effect of anticoagulants on plasma homocysteine determination. Clin Chim Acta. 2001;309:53-56.
38. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613-621.
39. Jonasson T, Ohlin H, Andersson A, Amadottir M, Hultberg B. Renal function exerts only a minor influence on high plasma homocysteine concentrations in patients with acute coronary syndromes. Clin Chem Lab Med. 2002;40:137-142.